PVLA Insider Trading Activity and SEC Form 4 Filings
PVLA insider trading summary
Over the past 12 months, insiders at Palvella Therapeutics, Inc. (PVLA) reported 63 sales worth $13.8M by 3 insiders and 3 open-market purchases worth $850K by 2 insiders on SEC Form 4. Net insider selling was $13.0M.
Latest PVLA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 21, 2026 | Kathleen Goin | Chief Operating Officer | Sell | $253K (2,043 @ $123.62) |
| Oct 21, 2026 | Kathleen Goin | Chief Operating Officer | Sell | $77K (607 @ $126.19) |
| Oct 21, 2026 | Kathleen Goin | Chief Operating Officer | Sell | $208K (1,663 @ $125.16) |
| Oct 14, 2026 | George M Jenkins | Director | Sell | $254K (2,072 @ $122.62) |
| Oct 14, 2026 | George M Jenkins | Director | Sell | $75K (597 @ $125.33) |
| Oct 14, 2026 | George M Jenkins | Director | Sell | $64K (505 @ $126.55) |
| Oct 14, 2026 | George M Jenkins | Director | Sell | $321K (2,604 @ $123.29) |
| Oct 14, 2026 | George M Jenkins | Director | Sell | $114K (920 @ $124.37) |
| Oct 14, 2026 | George M Jenkins | Director | Sell | $58K (476 @ $121.14) |
| Oct 13, 2026 | George M Jenkins | Director | Sell | $129K (990 @ $130.48) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.